Garuda Therapeutics has made significant strides in the development of novel therapies, with several projects in the pipeline. As Scientist I, Kaitlyn Bear's contributions in the research and development department have been instrumental in these advancements. Her expertise in molecular biology and genetic engineering has facilitated breakthroughs in targeted therapy development. Moving forward, Kaitlyn's focus will be on optimizing the therapeutic efficacy of our lead candidates, while also exploring potential new therapeutic targets. Her efforts will continue to be key in driving our mission to provide innovative treatments for unmet medical needs.More...